MCC AI/ML Community of Practice Group Group Convening Expert Panel to Explore “Using Machine Learning and Artificial Intelligence to Support Clinical Trials”

Wednesday, March 17, 2021

The MCC Artificial Intelligence / Machine Learning Community of Practice Group will host a panel discussion on 23 March at 11AM EDT to explore the topic: Using Machine Learning and Artificial Intelligence to Support Clinical Trials. 

Panel Moderator: Keith Dorricott, MCC Ambassador

Panelists:

  • Lucas Glass – VP, Analytics Center of Excellence, IQVIA
  • Ashley Howard – Associate Director, Asset Lead, Pfizer
  • Ilan Man – Head of Data Science and Analytics, Lokavant
  • Jonathan Rowe – Head of R&D Quality and Risk Management, ZS Associates

This promises to be a fascinating session with representatives from those who build ML/AI models, to an end-user and an experienced consultant in the industry. We’ve already had some interesting questions submitted – on whether AI/ML is just for big pharma, and strategies for overcoming resistance, for example.

The session is open to all MCC Members – contact MCC for registration details.

Additional information about this MCC Community of Practice Group is available on the MCC website.

Not a member? Contact Terry Holland, MCC Membership Director, to discuss membership options.